Filing Details
- Accession Number:
- 0000921895-25-002082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-04 19:23:01
- Reporting Period:
- 2025-07-30
- Filing Date:
- 2025-08-04
- Accepted Time:
- 2025-08-04 19:23:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1130166 | Cyclacel Pharmaceuticals Inc. | CYCC | Pharmaceutical Preparations (2834) | 911766850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1932843 | E. David Lazar | Ph The Towers, Tower 200, 30B Winston Churchill, Paitilla Panama City R1 07196 | No | No | Yes | No |
Transaction Summary
| Sold: | 6,750 shares | Avg. Price: $12.36 | Total Value: $83,430.00 |
| Number of Shares After Transactions: | 155,838 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-30 | 6,750 | $12.36 | 155,838 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The number Shares owned by the Reporting Person is reflective of a 1-for-15 reverse stock split effected by the Issuer on July 7, 2025 (the "Reverse Stock Split").
- Due to an inadvertent ministerial error, the Form 4 filed by the Reporting Person on February 28, 2025 reported beneficial ownership of 354,738 shares of the Issuer's Series D Convertible Preferred Stock which had already been converted into 162,588 shares of Common Stock (after giving effect to the Reverse Stock Split) as of such date.
Billionaire Hedge Funds
